Denali Therapeutics (NasdaqGS:DNLI) Update / briefing March 25, 2026 12:30 PM ET Speaker8Reminder, today's program is being recorded. Now I'd like to introduce your host for today's program, Laura Hansen, Vice President of Investor Relations. Please go ahead.Speaker4Thank you, Jonathan, and good day, everyone. Thank you for joining us today for our AVLAYAH FDA approval conference call. I'm Laura Hansen, Vice President of Investor Relations at Denali Therapeutics. Joining me on the call today are Ryan Watts, ...